Avacopan for the Treatment of ANCA-Associated Vasculitis
Summary: Patients who received avacopan were more likely to stay in remission versus those who were just taking prednisone.
Participating Penn Investigator(s): Dr. Peter Merkel
Journals:
- ACR Open Rheumatology, 2025. View 2025 Publication.
- New England Journal of Medicine, 2021. View 2021 Publication.
Disease(s): Eosinophilic Granulomatosis with Polyangiitis (EGPA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA)